https://fr180204inhibitor.com/....hoxb-family-genes-ge
The Kaplan-Meier strategy had been used to calculate general success (OS), disease-free success (DFS), local recurrence-free success (LRFS), and distant metastasis-free survival (DMFS). The log-rank technique was used to check the differences. The Cox regression design was utilized for the multivariate prognostic analysis.The follow-up price was 98.5%, and the median follow-up time ended up being 41.2 months. The complete 1-, 3-, and 5-year OS rates were 92.0%, 69.